Ridgetech, Inc. (RDGT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ridgetech, Inc. stock (RDGT) is currently trading at $0.11. Ridgetech, Inc. PS ratio (Price-to-Sales) is 0.46. WallStSmart rates RDGT as Sell.
- RDGT PE ratio analysis and historical PE chart
- RDGT PS ratio (Price-to-Sales) history and trend
- RDGT intrinsic value — DCF, Graham Number, EPV models
- RDGT stock price prediction 2025 2026 2027 2028 2029 2030
- RDGT fair value vs current price
- RDGT insider transactions and insider buying
- Is RDGT undervalued or overvalued?
- Ridgetech, Inc. financial analysis — revenue, earnings, cash flow
- RDGT Piotroski F-Score and Altman Z-Score
- RDGT analyst price target and Smart Rating
Ridgetech, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Ridgetech, Inc. (RDGT) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Ridgetech, Inc. (RDGT) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading at 1.87x book value, attractively priced
Supporting Valuation Data
Ridgetech, Inc. (RDGT) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -11.70%, a shrinking business
Very low institutional interest at 0.11%
Micro-cap company with very limited liquidity and high volatility
Decent profitability, keeps $10 per $100 revenue
Ridgetech, Inc. (RDGT) Detailed Analysis Report
Overall Assessment
This company scores 32/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.46), Price/Book (1.87) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -11.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -8.02%, Operating Margin at -0.12%, Profit Margin at 10.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -8.02% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -11.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
RDGT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
RDGT's Price-to-Sales ratio of 0.46x trades at a 25% premium to its historical average of 0.37x (82th percentile). The current valuation is 77% below its historical high of 2x set in Aug 2010, and 2210% above its historical low of 0.02x in Jan 2024. Over the past 12 months, the PS ratio has expanded from ~0.1x, reflecting growing market expectations outpacing revenue growth.
Compare RDGT with Competitors
Top PHARMACEUTICAL RETAILERS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Ridgetech, Inc. (RDGT) · HEALTHCARE › PHARMACEUTICAL RETAILERS
The Big Picture
Ridgetech, Inc. faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 120M with 12% decline year-over-year. Profit margins of 10.3% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 5M in free cash flow and 5M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 12% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Ridgetech, Inc. push profit margins above 15% as the business scales?
Sector dynamics: monitor PHARMACEUTICAL RETAILERS industry trends, competitive moves, and regulatory changes that could impact Ridgetech, Inc..
Bottom Line
Ridgetech, Inc. faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:27:54 AM
About Ridgetech, Inc.(RDGT)
NASDAQ
HEALTHCARE
PHARMACEUTICAL RETAILERS
USA
China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.